HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cornelia Winkelmann Selected Research

Therapeutics

12/2017Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
1/2010Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the 'Arbeitsgemeinschaft Internistische Onkologie'.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cornelia Winkelmann Research Topics

Disease

4Multiple Myeloma
12/2017 - 08/2012
4Pancreatic Neoplasms (Pancreatic Cancer)
07/2015 - 01/2010
1Neoplasms (Cancer)
07/2015
1Exanthema (Rash)
08/2014
1Disease Progression
05/2013
1Renal Insufficiency (Renal Failure)
08/2012

Drug/Important Bio-Agent (IBA)

4Bendamustine HydrochlorideFDA Link
12/2017 - 08/2012
4Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2015 - 01/2010
3Capecitabine (Xeloda)FDA Link
07/2015 - 01/2010
2Lenalidomide (CC 5013)FDA Link
12/2017 - 07/2013
2Prednisolone (Predate)FDA LinkGeneric
12/2017 - 07/2013
2Bortezomib (Velcade)FDA Link
11/2014 - 08/2012
2Prednisone (Sone)FDA LinkGeneric
11/2014 - 08/2012
2GemcitabineFDA Link
05/2013 - 01/2010
1Pharmaceutical PreparationsIBA
07/2015
1Biological ProductsIBA
07/2015
1Proteasome InhibitorsIBA
11/2014
1Biomarkers (Surrogate Marker)IBA
08/2014
1Cytostatic AgentsIBA
05/2013

Therapy/Procedure

2Therapeutics
12/2017 - 01/2010
2Drug Therapy (Chemotherapy)
07/2015 - 01/2010